Trifarotene
曲法罗汀
Report date: 2025/06/26 20:00:07
NME
Base Information
Drug NameTrifarotene
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2019/10/04
Country/Territory +[16]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGalderma Sa
China Registration ClassN/A
Develop Information
Active CompaniesGalderma SaGalderma R&DGalderma Laboratories Lp +[4]
Inactive CompaniesMayne Pharma International Pty LtdThe University Of Texas MD Anderson Cancer CenterTeva Pharmaceuticals Usa Inc +[4]
Active Indications
Inactive Indications